Company: HROW
Filing Date: 2025-11-10
Form Type: 10-Q
Source: 0001493152-25-021562
Chunk: 36

Company: HARROW, INC.
Filing Date: 2025-11-10
Form: 10-Q
Item: Item 1
Chunk 36
---
 stock to Mr. Boll, net of 136,745 shares of common stock withheld
for payroll tax withholdings totaling $3,157,000.

During
the nine months ended September 30, 2025, upon vesting of 762,300 PSUs granted in April 2023 to Mark L. Baum, the Company’s Chief
Executive Officer, the Company issued 461,937 shares of common stock to Mr. Baum, net of 300,363 shares of common stock withheld for
payroll tax withholdings totaling $6,935,000.

During the nine months ended September 30, 2025, 277,200 PSUs granted in April 2023 to John P. Saharek, the President of ImprimisRx,
vested, and the Company issued 167,725 shares of common stock to Mr. Saharek, net of 109,475 shares of common stock withheld for payroll
tax withholdings totaling $2,528,000.

In
July 2025, the Company issued 286,662 shares of common stock to Mark L. Baum, Chief Executive Officer, upon the cashless exercise of
options to purchase 600,000 shares at an exercise price of $7.87 per share. The Company withheld 127,345 shares from Mr. Baum as consideration
for the cashless exercise and an additional 185,993 shares for payroll tax obligations totaling $6,897,000.

During the nine months ended September 30, 2025, 42,500 RSUs granted in prior periods vested, and the Company issued 32,672 shares of
common stock, net of 9,828 shares of common stock withheld for payroll tax withholdings totaling $343,000.

During
the nine months ended September 30, 2025, 198,795 RSUs and PSUs granted in prior periods vested, and the Company issued 198,795 shares
of common stock.

During
the nine months ended September 30, 2025, the Company issued 28,108 shares of common stock and received proceeds of $287,000 upon the
exercise of options to purchase 28,146 shares of common stock with exercise prices ranging from $4.66 to $25.86 per share.

During
the nine months ended September 30, 2025, the Company issued 29,214 shares of its common stock underlying RSUs held by a director that
ceased providing services to the Company